Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb
- PMID: 15019774
- DOI: 10.1016/j.jmb.2004.01.038
Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb
Abstract
The hematopoietic transcription factor c-Myb activates transcription of target genes through direct interactions with the KIX domain of the co-activator CBP. The solution structure of the KIX domain in complex with the activation domain of c-Myb reveals a helical structure very similar to that adopted by KIX in complex with the phosphorylated kinase inducible domain (pKID) of CREB. While pKID contains two helices, alphaA and alphaB, which interact with KIX, the structure of bound c-Myb reveals a single bent amphipathic helix that binds in the same hydrophobic groove as the alphaB helix of pKID. The affinity of c-Myb for KIX is lower than that of pKID, and relies more heavily on optimal interactions of the single helix of c-Myb with residues in the hydrophobic groove. In particular, a deep hydrophobic pocket in KIX accounts for more than half the interactions with c-Myb observed by NMR. A bend in the alpha-helix of c-Myb enables a critical leucine side-chain to penetrate into this pocket more deeply than the equivalent leucine residue of pKID. The components that mediate the higher affinity of pKID for KIX, i.e. the phosphate group and the alphaA helix, are absent from c-Myb. Results from isothermal titration calorimetry, together with the structural data, point to a key difference between the two complexes in optimal pH for binding, as a result of differential pH-dependent interactions with histidine residues of KIX. These results explain the structural and thermodynamic basis for the observed constitutive versus inducible activation properties of c-Myb and CREB.
Similar articles
-
Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains.J Mol Biol. 1999 Apr 16;287(5):859-65. doi: 10.1006/jmbi.1999.2658. J Mol Biol. 1999. PMID: 10222196
-
Structural basis for cooperative transcription factor binding to the CBP coactivator.J Mol Biol. 2006 Feb 3;355(5):1005-13. doi: 10.1016/j.jmb.2005.09.059. Epub 2005 Oct 5. J Mol Biol. 2006. PMID: 16253272
-
Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.J Biol Chem. 2002 Nov 8;277(45):43168-74. doi: 10.1074/jbc.M207660200. Epub 2002 Aug 29. J Biol Chem. 2002. PMID: 12205094
-
Transcriptional activator-coactivator recognition: nascent folding of a kinase-inducible transactivation domain predicts its structure on coactivator binding.Biochemistry. 1998 Apr 28;37(17):5858-66. doi: 10.1021/bi9800808. Biochemistry. 1998. PMID: 9558319
-
Molecular recognition by the KIX domain and its role in gene regulation.Nucleic Acids Res. 2014 Feb;42(4):2112-25. doi: 10.1093/nar/gkt1147. Epub 2013 Nov 18. Nucleic Acids Res. 2014. PMID: 24253305 Free PMC article. Review.
Cited by
-
Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.PLoS One. 2012;7(12):e52906. doi: 10.1371/journal.pone.0052906. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300815 Free PMC article.
-
Characterization of partially ordered states in the intrinsically disordered N-terminal domain of p53 using millisecond molecular dynamics simulations.Sci Rep. 2020 Jul 24;10(1):12402. doi: 10.1038/s41598-020-69322-2. Sci Rep. 2020. PMID: 32709860 Free PMC article.
-
Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.PLoS Comput Biol. 2012;8(3):e1002420. doi: 10.1371/journal.pcbi.1002420. Epub 2012 Mar 15. PLoS Comput Biol. 2012. PMID: 22438798 Free PMC article.
-
The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.Mol Cancer Ther. 2015 Jun;14(6):1273-5. doi: 10.1158/1535-7163.MCT-15-0271. Epub 2015 May 20. Mol Cancer Ther. 2015. PMID: 25995438 Free PMC article. No abstract available.
-
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.Oncotarget. 2023 Mar 11;14:174-177. doi: 10.18632/oncotarget.28377. Oncotarget. 2023. PMID: 36913305 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
